IRIS
PACINI, FURIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.872
EU - Europa 6.065
AS - Asia 942
OC - Oceania 15
SA - Sud America 14
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.861
GB - Regno Unito 2.150
IE - Irlanda 937
IT - Italia 686
CN - Cina 629
UA - Ucraina 561
SE - Svezia 504
RU - Federazione Russa 427
FR - Francia 275
DE - Germania 271
SG - Singapore 182
FI - Finlandia 147
VN - Vietnam 56
BE - Belgio 29
TR - Turchia 25
ES - Italia 18
IN - India 18
NL - Olanda 17
AU - Australia 10
PL - Polonia 10
BR - Brasile 8
CA - Canada 8
EU - Europa 8
HK - Hong Kong 8
IR - Iran 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
AT - Austria 5
NZ - Nuova Zelanda 5
CH - Svizzera 4
CL - Cile 4
RO - Romania 4
HU - Ungheria 3
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
EG - Egitto 2
IL - Israele 2
IQ - Iraq 2
KR - Corea 2
MA - Marocco 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MX - Messico 1
MY - Malesia 1
PK - Pakistan 1
SN - Senegal 1
TH - Thailandia 1
Totale 13.929
Salva come PNG Salva come JPEG
Città #
Southend 2.033
Fairfield 1.258
Dublin 918
Woodbridge 594
Chandler 587
Ashburn 578
Wilmington 475
Seattle 470
Jacksonville 449
Houston 442
Cambridge 412
Ann Arbor 291
Siena 285
Nanjing 152
Princeton 150
Beijing 129
Singapore 127
Boardman 80
Helsinki 68
San Diego 64
Dong Ket 56
Nanchang 55
Moscow 47
San Mateo 42
Saint Petersburg 40
Düsseldorf 35
London 30
Shenyang 29
Florence 28
Brussels 27
Kunming 27
Shanghai 27
Jiaxing 26
Lancaster 26
Tianjin 26
Hebei 24
Izmir 21
New York 21
Milan 20
Prato 20
Dearborn 19
Changsha 18
Norwalk 18
Redwood City 18
Washington 18
Jinan 17
Zhengzhou 16
Málaga 15
Renton 13
Guangzhou 12
Ningbo 12
Venezia 12
Rome 11
Los Angeles 9
Menlo Park 9
Phoenix 9
Chicago 7
Hangzhou 7
Palermo 7
San Francisco 7
Saronno 7
Taizhou 7
Abidjan 6
Arezzo 6
Codogno 6
Melbourne 6
Munich 6
Naples 6
Salerno 6
Santa Clara 6
Brno 5
Dallas 5
Edinburgh 5
Toronto 5
Vienna 5
Frankfurt am Main 4
Hefei 4
Hong Kong 4
Lanzhou 4
Oak Park 4
Teverola 4
Amsterdam 3
Auckland 3
Bari 3
Belvedere Marittimo 3
Bonndorf 3
Brescia 3
Cincinnati 3
Delhi 3
Falls Church 3
Fuzhou 3
Gliwice 3
Lamezia Terme 3
Lausanne 3
Monteroni D'arbia 3
Sydney 3
Tappahannock 3
Zabrze 3
Zanjan 3
Auburn Hills 2
Totale 10.610
Salva come PNG Salva come JPEG
Nome #
null 398
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 235
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 235
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 210
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 209
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 201
Reference range of serum calcitonin in pediatric population 197
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer 197
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 190
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 188
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 180
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 174
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 174
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 173
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab 173
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 171
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer 170
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 168
Acute exogenous TSH administration stimulates leptin secretion in vivo 167
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone 166
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB) 165
Management of papillary thyroid microcarcinoma: primum non nocere! 164
Approach to and treatment of differentiated thyroid carcinoma 163
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 162
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update 157
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 155
Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer 153
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up 151
Definition and management of radioactive iodine-refractory differentiated thyroid cancer 149
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment 149
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 148
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 147
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 146
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 146
Changing natural history of differentiated thyroid cancer 145
Ernest L. Mazzaferri, MD, MACP (1936-2013) 145
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 143
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 143
Medullary thyroid carcinoma 142
Management of thyroid nodules: a clinicopathological, evidence-based approach 141
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 141
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 141
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 139
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 138
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question 135
Screening of thyroid nodules by serum calcitonin measurements: why not? 134
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 134
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 132
H. pylori (hp) infection and autoimmune diseases (ad): prevalence of infection in patients with Hashimoto's thyroiditis (ht) and allignement of thyroid hormones (th) with H. pylori proteins. 131
Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients 131
Observation for newly diagnosed micro-papillary thyroid cancer: is now the time? 129
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 129
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer 127
null 126
Management of differentiated thyroid cancer of the follicular epithelium 125
Post-thyroidectomy chronic asthenia: self-deception or disease? 125
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma 125
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis 125
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 123
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions 122
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? 122
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology 122
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 121
Telomeres and thyroid cancer 120
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal 120
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 116
Serum Ghrelin As a Marker of Atrophic Body Gastritis in Patients With Parietal Cell Antibodies 114
Rare diseases in clinical endocrinology: a taxonomic classification system 114
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 114
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 114
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study 113
Management of advanced medullary thyroid cancer 113
Targeted therapy in refractory thyroid cancer: current achievements and limitations 111
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients? 111
Medullary thyroid cancer: management guidelines of the American Thyroid Association 111
Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer 111
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 111
The low utility of pretherapy scans in thyroid cancer patients 109
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer 108
Multinodular goiter of unusual shape and location 107
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 105
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 105
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. Preface 103
Thyroid microcarcinoma 103
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 102
New insight in the follow-up strategies of differentiated thyroid cancer 101
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 101
Down modulation of IG20/MADD expression or phosphorylation renders TRAIL resistant thyroid cancer cells susceptible to TRAIL treatment 99
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 99
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer 98
null 94
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 94
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 93
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis 92
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 83
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 78
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 64
null 60
Manuale di medicina interna 57
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 56
Totale 13.671
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.866 0 0 0 0 211 217 293 400 289 231 62 163
2020/20212.322 84 232 66 219 166 289 133 376 178 234 161 184
2021/20221.285 132 183 71 100 68 53 62 41 82 143 142 208
2022/20231.961 115 173 262 271 194 387 38 173 214 32 73 29
2023/20241.265 69 30 107 39 52 355 463 19 6 18 16 91
2024/2025660 60 140 245 140 75 0 0 0 0 0 0 0
Totale 14.119